Allopurinol Tablets Recalled for Green Plastic Contamination
Preferred Pharmaceuticals is recalling Allopurinol 100mg tablets due to reports of a small green plastic piece embedded in tablets. This re-packaged medication was distributed in Indiana.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall involving foreign object contamination in a prescription medication. Although the contamination poses a risk of harm if ingested, the source text does not report any actual illnesses or injuries.
Plain-English summary
Preferred Pharmaceuticals, Inc. is recalling Allopurinol Tablets 100mg, USP (90-count bottles) due to the presence of a foreign substance—a small piece of green plastic embedded in the crack towards the edge of the tablet.
The recalled product is a re-packaged medication distributed in Indiana. The affected lot is K3022Q with an expiration date of March 31, 2025, bearing product number 68788-7383-09. Nine bottles have been identified in this recall.
Allopurinol is a prescription medication used to treat gout and prevent kidney stones. The presence of a foreign plastic object in the tablet creates a risk if ingested. No illnesses or injuries have been reported.
Consumers holding bottles from this lot should stop use and contact their pharmacy or healthcare provider. The medication should be returned to the dispensing pharmacy.
The recalled product
- Product
- Allopurinol Tablets 100mg, USP, 90-count bottles, Rx Only, 90, Mfg: Accord Healthcare, Inc; Durham, NC, PREFERRED Pharmaceuticals, Inc., The Physician's Solution, Prod#: 68788-7383-09.
- Manufacturer
- Preferred Pharmaceuticals, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- foreign-object
- contamination
- ingestion-hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: K3022Q
- Expiration date: 3/31/2025
Distribution
Distributed in 1 state:
- IN
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27